Weight-Loss Drugs Outperform Older Diabetes Pills in People with HIV, Real-World Study Finds
A nine-site U.S. cohort study found that GLP-1 receptor agonists produced roughly four times more weight loss than SGLT2 inhibitors ...
Tag: SGLT2 inhibitors
Weekly Semaglutide Outperforms Older Diabetes Pills in Protecting Failing Kidneys
A large real-world study finds once-weekly semaglutide outperforms sulfonylureas, DPP4 inhibitors, and thiazolidinediones on blood sugar, weight, blood pressure, and ...
Oral Semaglutide Shows Real-World Heart Protection in Diabetes Patients with Cardiovascular Disease
A large real-world study found that adults with type 2 diabetes and atherosclerotic cardiovascular disease who started oral semaglutide had ...
FDA Adverse Event Data Reveal Distinct Safety Profiles for Feline Diabetes Drugs Bexagliflozin and Velagliflozin
A pharmacovigilance analysis of nearly 6,000 FDA adverse event reports reveals that the two FDA-approved oral SGLT2 inhibitors for feline ...
Extra Pounds May Defy Expectations in Heart Failure, With or Without Diabetes
A large Korean cohort study shows that overweight heart failure patients survive longer than lean patients regardless of diabetes status, ...
Dual Diabetes Drug Therapy Linked to Lower Heart Attack and Stroke Risk
A new meta-analysis finds that combining SGLT2 inhibitors with GLP-1 receptor agonists is associated with lower risks of myocardial infarction ...
Fatty Liver Disease Is a Heart Problem Too: Experts Call for Joined-Up Care
An international expert panel calls for MASLD to be managed as a systemic cardiometabolic disease, proposing bidirectional heart–liver screening, fibrosis-based ...
Phosphatases Emerge as Promising Targets Against Diabetic Kidney Disease
A comprehensive review argues that classical protein tyrosine phosphatases, long considered undruggable, are central drivers of diabetic kidney disease and ...
Glucose-Lowering Drugs and Brain Health: Mechanisms, Evidence, and Future Directions
Scientists are taking a hard look at whether the world's most widely prescribed diabetes medications could do far more than ...
SGLT2 Inhibitors Linked to Cardiorenal Benefits Across CKM Syndrome Stages 2–4
A large analysis of clinical-trial evidence suggests that sodium-glucose cotransporter 2 (SGLT2) inhibitors protect the heart and kidneys across multiple ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!